Oxford Vaccine Faces More Questions After AstraZeneca Admits Error | Read

PUBLISHED ON: November 26, 2020 | Duration: 1 min, 11 sec

  
loading..
AstraZeneca Plc and the University of Oxford, among the front-runners in the quest to deliver a Covid-19 vaccine, face mounting questions about their trial results after acknowledging a manufacturing error. While an announcement Monday by Astra and Oxford showed their shot was 70% effective on average in a late-stage study, the scant details released by the UK partners have sparked worries about whether regulators would clear it. In a later statement, Oxford said a difference in manufacturing processes led to some participants being given a half dose instead of a full one.
ALSO WATCH
टीकाकरण के कुछ हफ्ते बाद एंटीबॉडी का कम होना क्या खतरनाक, बता रही हैं अंजलि इस्टवाल

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com